Stay updated on Pembrolizumab & Radiation in Soft Tissue Sarcoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Radiation in Soft Tissue Sarcoma Clinical Trial page.

Latest updates to the Pembrolizumab & Radiation in Soft Tissue Sarcoma Clinical Trial page
- Check6 days agoChange DetectedThe page revision tag was updated from v3.5.3 to v3.5.4, indicating a software/template update for the page. This change is administrative and does not alter the study content or eligibility criteria.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page's revision label was updated from v3.5.2 to v3.5.3, representing a minor metadata version update with no substantive changes to the study details.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page now displays Revision: v3.5.2. The previous Revision: v3.5.0 has been removed.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision: v3.5.0 updated for the study protocol document, replacing the previous v3.4.3 revision.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check99 days agoChange DetectedRevision: v3.4.2 was added, and the funding lapse notice and Revision: v3.4.1 were removed.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab & Radiation in Soft Tissue Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Radiation in Soft Tissue Sarcoma Clinical Trial page.